title: Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE.
authors.forename: Antonio
authors.initials: A
authors.lastname: Siniscalchi
authors.forename: Franco
authors.initials: F
authors.lastname: Mancuso
authors.forename: Luca
authors.initials: L
authors.lastname: Gallelli
authors.forename: Gallelli
authors.initials: G
authors.lastname: Luca
authors.forename: Guido Ibbadu
authors.initials: GI
authors.lastname: Ferreri
authors.forename: Guido Ferreri
authors.initials: GF
authors.lastname: Ibbadu
authors.forename: De Sarro
authors.initials: DS
authors.lastname: Giovambattista
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use*; D004347:Drug Interactions; D017029:Epilepsy, Complex Partial / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000077287:Levetiracetam; D011241:Prednisone; D010889:Piracetam